The use of 3D cell cultures is revolutionizing the drug testing industry, improving safety, accuracy and shaking up traditional methods. Could this technology take us into a future where we are able to fully personalize medicine, and maybe, even grow replacement organs? 

In this episode of Balancing the Future, Dr. Jan Lichtenberg joins Dana and Micah to explore how 3D cell cultures are changing the trajectory of the drug development and testing landscape, the ethical implications of this technology, and how all this fits into the context of personalized medicine.  

Dr. Jan Lichtenberg is CEO and co-founder of InSphero, a company that develops a wide range of 3D cell cultures and three-dimensional microtissues for drug development and screening.   

LINKS: 

Jan Lichtenberg on LinkedIn 

InSphero Website 

METTLER TOLEDO Laboratory Solutions Website 

METTLER TOLEDO Laboratory Solutions on LinkedIn 

Dana Clémençon on LinkedIn 

Micah Schweizer on LinkedIn 

Join hosts Dana Clémençon and Micah Schweizer on Balancing the Future from METTLER TOLEDO, where they delve into the world of sustainable technology and its transformative impact on our lives.  

Each episode features stories from leading innovators, breaking down complex tech advancements into engaging narratives that reveal how these innovations shape our present and future.  

From the origins of new technologies to their individual and societal implications, this podcast offers a compelling look at the future of sustainability.